Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Why Zimmer Biomet (ZBH) Stock Fell Today

None

Zimmer Biomet Holdings (ZBH) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a fresh Zimmer Biomet-specific filing or major corporate announcement tied directly to today’s selloff. The move looks more likely to reflect a broader medtech risk-off trade, with investors reacting to negative updates elsewhere in the medical device group and reassessing execution and supply-chain risks across orthopedic names.

Details:

  • Zimmer Biomet’s investor news page shows its most recent company update was an Aug. 28 quarterly dividend announcement, not a new operational warning or guidance cut.
  • The company’s Aug. 5 second-quarter report showed sales growth, adjusted earnings of $2.07 per share, and updated full-year 2026 guidance, so today’s drop does not seem tied to a newly reported earnings miss.
  • Zimmer Biomet also completed or pursued several strategic actions this year, including a larger share repurchase plan and the iovera acquisition, which can keep attention on integration, leverage, and execution risk when sector sentiment weakens.
  • This could be because investors sold the stock in sympathy with other medtech names after fresh peer updates pointed to operational disruptions and supply challenges, which weighed on the group today.
  • Sources:

    Zimmer Biomet, SEC, AP

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ZBH Insider Trading Activity

    ZBH Insider Trades

    $ZBH insiders have traded $ZBH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:

    • SANG YI (Group President, Asia Pacific) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $413,216.
    • LORI WINKLER (SVP and CHRO) sold 2,650 shares for an estimated $250,849

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $ZBH Hedge Fund Activity

    We have seen 400 institutional investors add shares of $ZBH stock to their portfolio, and 481 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $ZBH Government Contracts

    We have seen $11,641,141 of award payments to $ZBH over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $ZBH Congressional Stock Trading

    Members of Congress have traded $ZBH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $ZBH stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $ZBH Price Targets

    Multiple analysts have issued price targets for $ZBH recently. We have seen 10 analysts offer price targets for $ZBH in the last 6 months, with a median target of $95.0.

    Here are some recent targets:

    • Vik Chopra from BMO Capital set a target price of $95.0 on 07/09/2026
    • Vijay Kumar from Evercore ISI Group set a target price of $110.0 on 07/06/2026
    • Joanne Wuensch from Citigroup set a target price of $93.0 on 05/28/2026
    • Richard Newitter from Truist Securities set a target price of $92.0 on 04/29/2026
    • Rick Wise from Stifel set a target price of $105.0 on 04/29/2026
    • David Turkaly from Citizens set a target price of $105.0 on 04/29/2026
    • Larry Biegelsen from Wells Fargo set a target price of $90.0 on 04/29/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles